AbbVie Inc. (ABBV): Price and Financial Metrics

AbbVie Inc. (ABBV): $136.87

3.43 (+2.57%)

POWR Rating

Component Grades








Add ABBV to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




#2 of 167

in industry

ABBV Price/Volume Stats

Current price $136.87 52-week high $168.11
Prev. close $133.44 52-week low $131.10
Day low $133.50 Volume 6,661,600
Day high $136.97 Avg. volume 6,020,013
50-day MA $152.18 Dividend yield 4.29%
200-day MA $150.61 Market Cap 241.48B

ABBV Stock Price Chart Interactive Chart >


  • Quality is the dimension where ABBV ranks best; there it ranks ahead of 96.29% of US stocks.
  • ABBV's strongest trending metric is Growth; it's been moving down over the last 179 days.
  • ABBV ranks lowest in Stability; there it ranks in the 75th percentile.

ABBV Stock Summary

  • With a market capitalization of $249,029,488,332, ABBVIE INC has a greater market value than 99.42% of US stocks.
  • The capital turnover (annual revenue relative to shareholder's equity) for ABBV is 4.27 -- better than 88.67% of US stocks.
  • The volatility of ABBVIE INC's share price is greater than that of merely 5.96% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to ABBV, based on their financial statements, market capitalization, and price volatility, are PFE, NVS, CSCO, SHEL, and TMO.
  • ABBV's SEC filings can be seen here. And to visit ABBVIE INC's official web site, go to

ABBV Valuation Summary

  • ABBV's price/sales ratio is 4.4; this is 13.73% lower than that of the median Healthcare stock.
  • Over the past 126 months, ABBV's price/sales ratio has gone up 1.2.

Below are key valuation metrics over time for ABBV.

Stock Date P/S P/B P/E EV/EBIT
ABBV 2023-05-23 4.4 18.9 33.2 28.0
ABBV 2023-05-22 4.5 19.3 33.7 28.3
ABBV 2023-05-19 4.5 19.3 33.8 28.4
ABBV 2023-05-18 4.5 19.1 33.4 28.1
ABBV 2023-05-17 4.5 19.1 33.3 28.1
ABBV 2023-05-16 4.5 19.0 33.3 28.1

ABBV Growth Metrics

    Its 4 year price growth rate is now at 25.33%.
  • Its 5 year net income to common stockholders growth rate is now at 33.69%.
  • The year over year price growth rate now stands at 32.03%.
ABBV's revenue has moved up $3.1836e+10 over the prior 70 months.

The table below shows ABBV's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 58,054 24,943 11,836
2022-09-30 57,819 22,590 13,407
2022-06-30 57,349 22,923 12,637
2022-03-31 56,725 22,808 12,479
2021-12-31 56,197 22,777 11,542
2021-09-30 55,169 22,556 7,534

ABBV's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ABBV has a Quality Grade of B, ranking ahead of 80.75% of graded US stocks.
  • ABBV's asset turnover comes in at 0.369 -- ranking 131st of 682 Pharmaceutical Products stocks.
  • PLXP, HSTO, and ADMP are the stocks whose asset turnover ratios are most correlated with ABBV.

The table below shows ABBV's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.369 0.677 0.119
2021-06-30 0.359 0.656 0.102
2021-03-31 0.335 0.648 0.078
2020-12-31 0.339 0.664 0.070
2020-09-30 0.339 0.687 0.131
2020-06-30 0.372 0.736 0.147

AbbVie Inc. (ABBV) Company Bio

Abbvie develops and markets therapies that address a range of diseases. The Company's products are focused on treating conditions, such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis and Crohn's disease, hepatitis C, human immunodeficiency virus, endometriosis, thyroid disease, Parkinson's disease, complications associated with chronic kidney disease and cystic fibrosis, and other health conditions, such as low testosterone. The company was founded in 2012 and is based in North Chicago, Illinois.

ABBV Latest News Stream

Event/Time News Detail
Loading, please wait...

ABBV Latest Social Stream

Loading social stream, please wait...

View Full ABBV Social Stream

Latest ABBV News From Around the Web

Below are the latest news stories about ABBVIE INC that investors may wish to consider to help them evaluate ABBV as an investment opportunity.

AbbVie (ABBV) Gets FDA Nod for Lymphoma Drug Epcoritamab

The FDA approves AbbVie's (ABBV) epcoritamab, to be marketed as Epkinly, for relapsed/refractory large B-cell lymphoma, a form of NHL. Epkinly is AbbVie's third blood cancer drug.

Yahoo | May 22, 2023

Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy

(Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a promising treatment for digestive disorders to its portfolio. Ironwood has offered $17 per share for VectivBio, a premium of about 43% to the stock's last close. VectivBio's shares were at $16.21 in morning trade, while Ironwood's stock fell 4.5% to $10.

Yahoo | May 22, 2023

12 Cheap Dividend Stocks With High Yields

In this article, we discuss 12 cheap dividend stocks with high yields. You can skip our detailed analysis of value stocks and their past performance, and go directly to read 5 Cheap Dividend Stocks With High Yields. The Importance of Investing in Undervalued/Cheap Stocks Investing in value stocks is one of the most popular methods to […]

Yahoo | May 21, 2023

Is There An Opportunity With AbbVie Inc.'s (NYSE:ABBV) 43% Undervaluation?

Key Insights Using the 2 Stage Free Cash Flow to Equity, AbbVie fair value estimate is US$255 AbbVie's US$145 share...

Yahoo | May 21, 2023

3 Relatively Safe Stocks to Buy if a Recession Is on the Way

Here's why three Motley Fool contributors think that AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Johnson & Johnson (NYSE: JNJ) are relatively safe stocks to buy if a recession is declared this year. Prosper Junior Bakiny (AbbVie): It may be hard to believe that AbbVie is a safe stock right now.

Yahoo | May 20, 2023

Read More 'ABBV' Stories Here

ABBV Price Returns

1-mo -7.12%
3-mo -11.49%
6-mo -14.94%
1-year -3.39%
3-year 71.38%
5-year 74.41%
YTD -13.72%
2022 24.01%
2021 32.43%
2020 27.72%
2019 1.47%
2018 -0.96%

ABBV Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full ABBV Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!